新冠疫情头两年国家免疫技术咨询小组指南中使用的COVID-19疫苗获益与风险直接定量比较
本研究通过检索MEDLINE和全球NITAG网络网站,纳入7个NITAG使用的18项直接定量比较(DQC)的23篇出版物,描述DQC在NITAG指南中的作用、方法及局限性。DQC因简单易行而及时透明,但高度依赖假设、难以迁移至其他情境且快速过时;若成为标准做法需解决其局限性。
要点
- 7个NITAG在23篇出版物中使用了18项DQC,触发情境包括新安全信号、已有安全信号的新信息及情境变化。
- DQC简单易行,使其易于获取、及时且沟通透明。
- DQC高度依赖假设,对模型参数变化敏感,难以迁移至其他情境且快速过时。
核心结论
- NITAG在COVID-19大流行期间使用DQC,得以在演变环境中快速做出循证决策并维持公众信任;若其使用成为标准做法,应努力解决其局限性。
研究设计与样本
- 检索MEDLINE数据库和全球NITAG网络列出的NITAG网站,纳入明确使用任何COVID-19疫苗获益与风险DQC进行NITAG决策的出版物,由两名评价员独立评估资格并提取数据,进行叙述性描述。
主要发现
- 共纳入23篇出版物,涉及7个NITAG使用的18项DQC。
- 触发这些出版物的情境包括新安全信号(n=7)、关于先前已识别安全信号的额外信息(n=4)和变化的情境(n=15)(如疫苗供应和流行病学)。
- DQC的简单性使其易于获取、及时并允许透明沟通。
- DQC高度依赖假设,使其对模型参数变化敏感。
- DQC的局限性使其不易迁移至其他情境,且在COVID-19大流行的演变情境中迅速过时。
关键数值与推荐
- 纳入标准为出版物中明确使用任何COVID-19疫苗获益与风险的DQC进行NITAG决策。
- 共识别7个NITAG使用的18项DQC,发表于23篇出版物。
- 触发情境:新安全信号n=7,先前已识别安全信号的额外信息n=4,变化的情境n=15。
临床怎么用
- 原文未据此给出推荐。
局限性
- DQC高度依赖假设,使其对模型参数变化敏感。
- DQC的局限性使其不易迁移至其他情境,且在COVID-19大流行的演变情境中迅速过时。
- 若DQC的使用成为标准做法,应努力解决其局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The balance of benefits and harms of vaccines are assessed by regulatory agencies and National Immunization Technical Advisory Groups (NITAGs) to inform vaccine authorization or guidance. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach has been adopted by many NITAGs to develop recommendations. During the COVID-19 pandemic, several NITAGs additionally used direct quantitative comparisons (DQCs) between benefits and risk of vaccination with or without a GRADE framework to support timely decision-making relating to emerging safety signals. This study aimed to document the role of DQCs as novel tools in NITAGs' work by identifying situations where DQCs have been clearly leveraged in NITAG guidance, as well as identifying their strengths and limitations. METHODS: The MEDLINE database and NITAGs' websites listed in the Global NITAG Network were searched for NITAG publications on COVID-19 vaccines. Publications were included if a DQC between benefits and risks of any COVID-19 vaccine was explicitly used for NITAG decision-making. Two reviewers independently assessed publication eligibility and extracted data. A narrative description of the role of DQCs in NITAG guidance, DQCs' methods and limitations was conducted. RESULTS: Overall, 23 publications with 18 DQCs used by seven NITAGs were included. Situations prompting these publications included new safety signals (n = 7), additional information available on previously identified safety signals (n = 4) and changing contexts (n = 15) (e.g., vaccine supply, and epidemiology). DQC simplicity made them accessible, timely, and allowed for transparent communication. DQCs heavily relied on assumptions making them sensitive to changes in model parameters. DQCs limitations made them not easily transferable to other contexts and they quickly became obsolete in the evolving context of the COVID-19 pandemic. CONCLUSIONS: The use of DQCs by NITAGs during the COVID-19 pandemic allowed for rapid evidence-based decision-making in an evolving environment while maintaining public trust. However, if their use becomes standard practice, efforts should be made to address their limitations.
引用
- Doyon-Plourde P, Farley R, Krishnan R, et al. Direct quantitative comparison of benefits and risks of COVID-19 vaccines used in National Immunization Technical Advisory Groups Guidance during the first two years of the pandemic. Vaccine. 2024. PMID: 39388931. doi:10.1016/j.vaccine.2024.126406
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。